Showing 17,561 - 17,580 results of 45,491 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.29s Refine Results
  1. 17561

    Table_2_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  2. 17562

    Image_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.pdf by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  3. 17563

    Operationalising Factors That Explain the Emergence of Infectious Diseases: A Case Study of the Human Campylobacteriosis Epidemic by Norval J. C. Strachan (235193)

    Published 2013
    “…The study focused on Scotland between 1990–2012 where there was a 75% increase in reported cases that included >300% increase in the elderly and 50% decrease in young children. …”
  4. 17564

    Table_4_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  5. 17565

    Table_3_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  6. 17566

    Analysis of BCL11A gene polymorphisms and hemolysis parameters in patients with sickle-cell disease by Marilia R. Laurentino (5629814)

    Published 2018
    “…The use of HU at doses ≥ 10 mg/kg/day showed a decrease of LDH (p = 0.02), and treatment for > 50 months was linked to the reticulocyte count (p = 0.0155). …”
  7. 17567

    Table_5_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

    Published 2019
    “…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
  8. 17568

    Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial by Samuel Oliveira de Afonseca (12798419)

    Published 2022
    “…Previous studies have shown that vitamin E can reduce the incidence of peripheral neuropathy by 50%. This study aimed to assess the effectiveness of vitamin E for prevention of oxaliplatin-induced peripheral neuropathy.DESIGN AND SETTINGProspective, phase II, randomized pilot study developed at a university hospital in the Greater ABC region.METHODSPatients were randomized five days before starting oxaliplatin treatment, to receive either vitamin E or placebo until the end of the chemotherapy regimen. …”
  9. 17569

    Rab7A depletion affects Env processing and the incorporation of mature Env into viral particles. by Marina Caillet (198168)

    Published 2011
    “…This experiment is representative of 3 independent experiments done in duplicate. (<b>A</b>) Equal amounts of cell lysate (50 µg protein) were loaded to visualize the intracellular accumulation of viral proteins in Rab7A-depleted cells. …”
  10. 17570

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  11. 17571

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  12. 17572

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  13. 17573

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  14. 17574

    Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

    Published 2006
    “…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
  15. 17575
  16. 17576
  17. 17577
  18. 17578
  19. 17579
  20. 17580